Due to its increasing incidence and low survival rate, esophageal cancer (EC) is now considered, even by non-medical professionals, as an extremely difficult cancer to beat akin to well-known terminal indications such as pancreatic and lung cancers.
http://journal.frontiersin.org/article/10.3389/fonc.2017.00063/full
“Targeted†Chemotherapy for Esophageal Cancer